✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Fredun Pharmaceuticals Ltd.

FREDUN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹732 Cr.
P/E
37.11

Fredun Pharmaceuticals Ltd.

  • Fredun Pharma
  • Shivalik Rasayan
  • Kilitch Drugs(India)
  • TJI Pharma - Small Cap

FAQs on Fredun Pharmaceuticals Ltd. Shareprice

Fredun Pharma has given better returns compared to its competitors.
Fredun Pharma has grown at ~32.57% over the last 4yrs while peers have grown at a median rate of 12.64%

Fredun Pharma is not expensive.
Latest PE of Fredun Pharma is 37.11, while 3 year average PE is 44.44.
Also latest EV/EBITDA of Fredun Pharma is 14.55 while 3yr average is 18.27.

View FAQ's On Business

Growth Table

  • Fredun Pharmaceuticals Ltd.
  • Shivalik Rasayan
  • Kilitch Drugs(India)

Balance Sheet

  • Fredun Pharmaceuticals Ltd.
  • Shivalik Rasayan
  • Kilitch Drugs(India)

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Fredun Pharmaceuticals Ltd.
  • Shivalik Rasayan
  • Kilitch Drugs(India)

Cash Flow

  • Fredun Pharmaceuticals Ltd.
  • Shivalik Rasayan
  • Kilitch Drugs(India)

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Fredun Pharmaceuticals Ltd.
  • Shivalik Rasayan
  • Kilitch Drugs(India)

Quarterly Results

  • Fredun Pharmaceuticals Ltd.
  • Shivalik Rasayan
  • Kilitch Drugs(India)

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Fredun Pharmaceuticals Ltd. Financials

Balance sheet of Fredun Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Fredun Pharma is increasing.
Latest net debt of Fredun Pharma is ₹157 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹103 Crs.

The profit is oscillating.
The profit of Fredun Pharma is ₹12.77 Crs for TTM, ₹19.74 Crs for Mar 2025 and ₹15.62 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Fredun Pharma latest dividend payout ratio is 1.67% and 3yr average dividend payout ratio is 2.24%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech